Is Big Pharma Ready to Meet the Challenges of Election Year 2020?

Pharmacy casework

Integrated stainless steel workbench

Guardian pharmacy

Adjustable angled shelves packing station

Custom storage pharmaceutical filling station

The pharmaceutical industry is facing a wide range of challenges in the coming year of 2020. Click now to read about those challenges.

AUSTIN, TEXAS, USA, December 9, 2019 /EINPresswire.com/ — The pharmaceutical industry is facing a wide range of challenges, including the changing market conditions for so-called blockbuster drugs, increased market penetration by generic drug makers, the risk of carcinogen contamination in common consumer drug prescriptions, potential changes in drug pricing regulations in the run-up to the 2020 election, and even market challenges and opportunities stemming from Britain leaving the European Union.

What’s disrupting today’s blockbuster drug development pipeline? For the pharmaceutical industry, it’s all about the pipeline.

When things are working on all cylinders, it goes like this: pharma companies spend exorbitant amounts of money on research and development of drug candidates — many are expected to fail during clinical trials.

Pressure mounts on those few drugs in the pipeline that make it through the years-long approval process gauntlet — will they rise to the pantheon of “blockbuster” drugs?

The drug makers certainly hope so. In fact, many pharma execs bet their companies on a series of blockbuster drugs to provide the necessary billions of dollars in ROI earned over the life of their drug patents to recoup all their initial investment and to make enough profits to pay for the next round of drugs in the pipeline.

But is the classic era of the blockbuster drug over? Indeed, there’s a concern that the rate of discovery of new blockbuster drugs has slowed down.

What seems to be happening now is that fewer, but more powerful “blockbuster” patent drugs are coming to market, including new miracle drugs offering the hope of life-changing cures for diseases such as liver cancer / Hepatitis C.

Adding to the financial challenges are increased drug development costs and the fact that many pharma giants are spending vast sums on acquisitions to add to their drug portfolios.

Formaspace creates custom installations for pharma research labs, product production facilities, and drug packaging facilities. Shown above is an integrated pharma packaging line that features a custom weighing scale cut out; convenient, easily accessible storage; and custom workbenches that are functional, sturdy, and built for years of constant use.

Curing a chronic disease is a miracle for patients. But who pays for the development costs of these extraordinary drugs? That’s the billion-dollar question. Here’s a relevant example: what price would you pay to cure a single case of Hepatitis C? The answer may be a $100,000 per patient, a price that some say makes perfect economic sense in light of the costs incurred during the drug development pipeline. But it’s a shock to the consumer and to the insurance payers, many of whom are struggling to pay these one-time costs, even when it offers the potential of a lifetime cure.

Furious negotiations and lobbying efforts are taking place across the nation between drug companies and the states to find ways to spread the cost of treatment across a broader spectrum of patients to bring the cost down for each individual.

Meanwhile, politicians in Washington are getting the message that drug prices are too high, and something needs to be done about it. Advocates for lower drug prices have lobbied hard for relief, arguing that Americans pay more than their fair share for drugs compared with consumers in other countries.

Surprisingly, there has been a somewhat bi-partisan bill in Congress: The Prescription Drug Pricing Reduction Act (PDPRA) of 2019.

The bill caps some Medicare drug prescription prices based on a formula that takes into account the cost that consumers in other countries pay. As expected, opinion is divided: consumer advocates hail the idea of Medicare using its pricing power to get discounts from drug companies, while pharma industry representatives and conservative commentators argue this will have a devastating impact on drug development.

Formaspace built these custom workbenches for a pharmaceutical company that fills drug orders for care facilities and nursing homes.

Read more … https://formaspace.com/articles/pharmaceuticals/pharma-challenges-for-2020/?utm_source=einpresswire&utm_medium=content&utm_campaign=article-120519

Mehmet Atesoglu
Formaspace
22792792
email us here


Source: EIN Presswire

Global Nano-drug Market 2019 Industry Analysis, Opportunities, Segmentation & Forecast To 2026

Wiseguyreports.Com Adds “Nano-drug – Global Market Growth, Opportunities, Analysis Of Top Key Players And Forecast To 2026” To Its Research Database.

PUNE, MAHARASTRA, INDIA, December 9, 2019 /EINPresswire.com/ — Global Nano-drug Market 2019-2026

Market Overview:

The Nano-drug is a branch of nanotechnology. Nano-drugs range from nanomaterial applications in the medical field to nanoelectronic biosensors. Nono-drugs have the capability of delivering effects to specific cells, using its nanoparticles. These drugs are widely utilized across the major healthcare organizations to treat some severe health conditions. Nano-drug delivers the rug to intended cells, thereby reducing the side effects. Nanoparticles present in the nano-drugs have a great surface area to volume ratio, which allows them to cure the tumor or cancer cells effectively.

Nano-drug with complete research is recommended by doctors due to their effectiveness in treating the infected cells. Nano-drug is effective in treating cancer. They target the tumor cells that are responsible for causing cancer, without leaving any side effect on the normal cells. There are many types of research done on Nano-drug and researchers are getting favorable outcomes, which has laid the foundation for the growth in the Nano-drug market. Nano-drugs have also been an effective tool in imaging the ultrasound and MRI. Nano-drug has developed a new treatment concept in the medical field and are expected to become popular in coming time

The Global Nano-drug Market Report 2019 presents detailed information on production and manufacturing, emerging market trends, and other important factors in the nano-drug market. The report discusses the scope for growth, key areas for growth, etc in the nano-drug market, based on the historical and statistical data available for the period 2014-2018. The report comes with thorough research data on the nano-drug market, covering all the critical information on the latest trends, market dynamics, and other influential factors. The report predicts the future trends and scope of the market for the forecast period 2019-2026.

Major players in the global Nano-drug market include:
OSI Pharmaceuticals
Samyang Biopharm
Novartis
Novavax
Eli Lilly
Navidea Biopharmaceuticals
Lummy
Mitsubishi Pharma
Abbott
Gilead Sciences
Johnson&Johnson
Stryker
Cerulean Pharma
Roche
Celgene
Sanofi
Selecta Biosciences
Kaken Pharmaceutical
Pfizer
Astrazeneca
Merck
Kadmon Pharmaceuticals
GlaxoSmithKline
Par Pharmaceutical

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4251764-global-nano-drug-market-report-2019-competitive-landscape-trends-and-opportunities

If you have any special requirements, please let us know and we will offer you the report as you want.

Market Segmentation:

The nano-drug is seeing a favorable verdict in research done by scientists, which has been helping the market growth worldwide. Nano-drugs have been effective in treating many diseases, by targeting the cause of the disease without any side effects to other body parts, which has been the major market driver for the nano-drug market. For a better understanding of the nano-drug market, the market is segmented into two parts, on the basis of types and applications. The types segment includes Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion and Nanoemulsion, and Nanosuspension. The applications segment includes Cancer and Tumors, Autoimmune Disorders, and Heart Disease.

Regional Overview:

The market report on the nano-drug market analyzes the market at the company, country, regional and global levels. The report provides insights about the present market trends, growth opportunities, recent market developments, threats, Market drivers, restraints, market forces, and the key players in the nano-drug market at the regional levels. The report examines the risks and challenges associated with the nano-drug market, which would help the companies entering the market to get a complete knowledge of the market. The report analyzes factors like consumption rate, market revenue, market share, etc in the regions of Central and South America, where Brazil, Mexico, and Colombia would be the lead markets for growth. The report also analyzes the market in the regions of the US, Europe, China, India, Japan, MEA, etc. The report also covers the key regions for growth present in these areas.

Industry News:

The Ministry of Science and Technology of India released new guidelines for the evaluation of nano drugs. The Ministry announced that a three-day conference would be conducted with experts regarding the use of biotechnology, in association with the Biotechnology Industry Research Assistance Council (BIRAC). The conference meet will discuss the challenges in bio-agriculture too, including policy dialogues for the biotechnology.

Continued…..

Enquiry Before Buying @ https://www.wiseguyreports.com/enquiry/4251764-global-nano-drug-market-report-2019-competitive-landscape-trends-and-opportunities

NORAH TRENT
Wise Guy Reports
841-198-5042
email us here


Source: EIN Presswire

Exclusive interview from Christiane Niederlaender, Director at AMBR Consulting, released ahead of SMi’s RNA Therapeutics

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

SMi has released an exclusive interview with Christiane Niederlaender, Director at AMBR Consulting Ltd, ahead of the upcoming RNA Therapeutics conference.

LONDON, UNITED KINGDOM, December 9, 2019 /EINPresswire.com/ — SMi’s 11th annual RNA Therapeutics conference, taking place on 19th – 20th February in London, will bring together industry experts from leading RNA therapeutics companies to discuss the challenges for clinical translation of RNA-based therapeutics. The two-day event will present an overview of the applications of RNA-based drugs for modulation of gene and protein expression, and genome editing, with a focus on recent developments in delivery technologies.

SMi recently interviewed industry expert Christiane Niederlaender, Director at AMBR Consulting Ltd, who will be speaking at the RNA Therapeutics conference. Here is a snapshot of what was discussed:

The Oligonucleotide Therapeutics market has matured greatly over recent years, what key differences have you noticed in the last year regarding significant developments?

“The Oligonucleotide sector has seen an increase in regulatory approval, in particular, for the RNAi based therapies. My personal focus, however, is on RNAs that are biological medicines, and in this sector I see a lot of promise in the new mRNA-based vaccines, some of which are biologicals, where new developments mean that these products are now more stable, and have better translation. At the same time, CRISPR Cas approaches are now entering the clinic and the very first clinical results seem to show promise.”

What are your thoughts on the developing regulatory expectations around RNA Therapeutics and how is this currently impacting your role?

“From a regulatory perspective CRISPR Cas approaches are perhaps the most challenging. Due to the specifics of the legislation in Europe, these products can fall into a variety of medicine categories each with slightly differing regulatory implications. I think it will be important for regulators to come to an understanding of how to standardize their regulation bearing the risk profile in mind. Some of these considerations also apply to mRNA therapies.”

The full version of the interview and event brochure are available to download online at
www.therapeutics-rna.com/EINpr6

Christiane Niederlaender will be presenting on "When RNA Therapeutics are Biological Medicines: Regulatory Considerations for the EU":
• Classifications of RNA therapeutics within the medicines framework
• RNAs in CRISPR approaches and the CMC considerations
• Key regulatory issues as highlighted by case studies

RNA Therapeutics
Focus Day: 18th February 2020
Conference: 19th – 20th February 2020
Copthorne Tara Hotel, London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

— ENDS –

Contact Information:
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6168
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Neill Howard
SMi Group Ltd
+44 20 7827 6000
email us here


Source: EIN Presswire

RNA Therapeutics 2020 to Highlight Developments in Delivery Mechanisms

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

SMi Reports: Delivery Mechanisms will be a key focus of the RNA Therapeutics conference taking place in London on 18th – 20th February 2020.

LONDON, UNITED KINGDOM, December 9, 2019 /EINPresswire.com/ — SMi’s 11th annual RNA Therapeutics conference will take place in London on 18th – 20th February. This year’s event will explore the latest discoveries in oligonucleotide-based therapeutics, novel mRNA technology, immunotherapy and vaccines. Developments in delivery mechanism technologies will feature as a key topic.

Researchers have seen promising results related to major challenges in the field of delivery mechanisms. RNA Therapeutics 2020 will feature expert presentations related to overcoming these challenges, including, intracellular delivery, stability and immune response activation.

Presentations Highlighting Delivery Mechanisms include:

Optimising Nanoparticle Mediated Delivery of siRNAs to Treat Cancer and Fibrosis
– David Evans, CSO, Sirnaomics, Inc

Design of Safe and Potent Nucleic Acid Therapeutics
– Pete Lutwyche, CTO, Genevant Sciences

Overcoming Lung Barriers to siRNA Delivery in Cystic Fibrosis through Tailored Lipid/Polymer Hybrid Nanaparticles
– Francesca Ungaro, Associate Professor, University Of Napoli Federico Ii

Aiming at Delivering RNA to Tumours Using Intra-Venous Injections
– Steve Pascolo, Founder and CEO, Miescher Pharma

RNA Therapeutics 2020 will feature presentations by more than 18 industry leaders. In addition to delivery technologies, experts will cover topics, such as, clinical translation, applications of RNA-based drugs for modulation of gene and protein expression and genome editing.

For further details visit www.therapeutics-rna.com/EINpr5

RNA Therapeutics
Focus Day: 18th February 2020
Conference: 19th – 20th February 2020
Copthorne Tara Hotel, London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

— ENDS –

Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Neill Howard
SMi Group Ltd
+442078276020
email us here


Source: EIN Presswire

Global Power Battery Market Report 2019 by Technology, Future Trends, Opportunities, Top Key Players and more…

A new market study, titled “Global Power Battery Market Professional Survey Report 2019”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, December 9, 2019 /EINPresswire.com/ — Power Battery Market

The global Power Battery market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Power Battery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Power Battery market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Power Battery in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Power Battery manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
BAK Group
Mitsubishi Electric
BYD Company
LG Chem
Panasonic
Samsung SDI
GS Yuasa
Hitachi
Johnson Controls
Saft Group
Toshiba
Sony
EnerSys
CSB Battery
Sebang
East Penn
Fiamm
NorthStar
Atlasbx
ACDelco
Trojan
Midac Power
Narada Power
Camel
Leoch
Shoto
A123 Systems
Valence Technology
Shenzhen Lithpower Technology
Future Hi-Tech Batteries

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4697941-global-power-battery-market-professional-survey-report-2019

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Lithium-ion Battery
Lead Acid Battery
Fuel Cell
Nickel-Cadmium Battery
NiMH Battery
Others

Segment by Application
Electric Vehicles
Electric Bicycles
Industrial Power System
Other

Table of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst's Viewpoints/Conclusions
15 Appendix

View Detailed Report at https://www.wiseguyreports.com/reports/4697941-global-power-battery-market-professional-survey-report-2019

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+1 646-845-9349
email us here


Source: EIN Presswire

Nematodes successfully launched into space for first ever agricultural bio-control experiment on ISS

SpaceX CRS 19 Dragon capsule approaches to the ISS

Hard working beneficial nematodes are finally on their way to the International Space Station

It’s a scientist’s dream come true.”

— Dr. Fatma Kaplan, Project Director and CEO of Pheronym

MERRITT ISLAND, FL, UNITED STATES, December 8, 2019 /EINPresswire.com/ — Pheronym, a bio-ag-tech pest control company, announced today that its first-ever agricultural bio-control experiment featuring beneficial nematodes is on its way to the International Space Station (ISS) U.S. National Laboratory after a successful launch today at the Kennedy Space Center. The nematodes were on a SpaceX Falcon9 rocket on December 5, 2019, launching the 21st Dragon spacecraft mission on its 19th commercial resupply delivery flight to the ISS. The science will focus on Pheronym’s breakthrough nematode bio-remediation technology and determine the impact that space travel has on the ability of beneficial nematodes to effectively manage pest control as well as other benefits for agriculture here on Earth. The nematodes reached the ISS on SpaceX Dragon capsule on Sunday, December 8 at 5:05 AM Eastern Time.

The research is sponsored by the ISS National Lab, who partners with NASA to utilize research allocation aboard the orbiting laboratory. Once aboard the space station, the project itself will be conducted inside of a NanoRacks’ NanoLab. NanoRacks, a for-profit hardware facility partner that supports research on the space station, will manage the manifesting, NASA safety review, integration, launch logistics, and on-orbit operations. All of this will be done in coordination with, and under the ISS National Lab flight allocation.

“For agriculture to work in space we must have sustainable, non-toxic methodologies for pest control,” said Dr. David Shapiro-Ilan, Co-Project Director and Research Entomologist at the USDA. “Pheronym’s proven approach to bioremediation has great promise of being an important part of that solution and advances our fundamental understanding of parasitism and pathogenesis.”

“It’s a scientist’s dream come true,” said Dr. Fatma Kaplan, Project Director and CEO of Pheronym. “We thank the USDA, NASA and the ISS for the privilege and opportunity to move our science forward for the benefit of agriculture on our planet and beyond.”

To commemorate the achievement of this first-ever experiment, Pheronym, in conjunction with the ISS National Lab, has approved an official mission patch, which can be seen at www.astronematode.com.

For more information and to see how you can participate in the mission, follow @AstroNematode on social media (Twitter, Linkedin, Facebook, and Instagram) and support our crowdfunding campaign. Proceeds will fund continued experiments and commercialization of Pheronym’s technology.

About Pheronym:
Award-winning Pheronym is an ag-biotech pest management company that enables sustainable farming through its novel platform of nematode pheromones. Based in MERRITT ISLAND, Florida and DAVIS, California, the company uses a new pheromone to control plant-parasitic nematodes (microscopic roundworms) in an eco-friendly way and enhances beneficial nematodes’ efficacy to eliminate pest insects. Learn more at www.pheronym.com.

About NanoRacks:
NanoRacks LLC, an XO Markets company, is the world’s first commercial space station company with an existing customer base. The company offers low-cost, high-quality solutions to the most pressing needs for satellite deployment, basic and educational research, and more – both at home and in over 30 nations worldwide. Since 2009, Texas-based NanoRacks has truly created new markets and ushered in a new era of in space-services, dedicated to making space just another place to do business.

About the International Space Station (ISS) U.S. National Laboratory:
In 2005, Congress designated the U.S. portion of the ISS as the nation’s newest national laboratory to optimize its use for improving quality of life on Earth, promoting collaboration among diverse users, and advancing science, technology, engineering, and mathematics (STEM) education. This unique laboratory environment is available for use by non-NASA U.S. government agencies, academic institutions, and the private sector. The ISS National Lab manages access to the permanent microgravity research environment, a powerful vantage point in low Earth orbit, and the extreme and varied conditions of space.

Karl Cameron Schiller
Pheronym, Inc.
+1 352-283-6967
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Groom & Associates responds to the high demand for technology and engineering talent by changing their focus.

Groom and Associates

Canada’s leading recruitment firm Groom Associates now specializes in recruiting talent for specific sectors.

MONTREAL, TORONTO, QUEBEC, ONTARIO, CANADA, December 6, 2019 /EINPresswire.com/ — Previously known as Canada’s leading recruitment firms for a wide range of industries, Groom & Associates now specializes in recruiting talent for specific sectors.

“We now serve the IT and AI, Life Sciences, Engineering and Industrial, and Finance industries exclusively,” says Karen Groom, founder and CEO of Groom.

As Canadian cities are becoming important hubs for AI research, and as the country’s pharmaceutical market is predicted to grow to $25 billion by 2021 according to various reports, demand for tech and engineering specialists seems to be outpacing supply.

“Engineers, data scientists, and other IT professionals have a lot of choice when it comes to where they want to work. Biopharma and tech companies are popping up all over the country, and they all require highly skilled people,” explains Groom.

One notable challenge faced by employers in these industries is hiring specialists who possess both leadership and managerial experience.

“We work with clients seeking to fill roles that simply didn’t exist 10 or even 5 years ago, such as Blockchain Engineer or Data Scientist. It means that people with the hard skills for these emerging roles might have the talent, but not necessarily years of executive experience,” she says.

Canadian employers turn to Groom when looking to fill AI, IT, and engineering roles because many of the recruiters at Groom & Associates have education or work experience in the STEM fields themselves. They’re able to genuinely connect with candidates to ensure a sound understanding of what a candidate wants, and whether or not their skills and attitude suit the role in question – including managerial positions. According to Groom, employers must also promote their corporate culture and other variables in order to attract talent.

“It’s important that companies promise more than a competitive salary; they must offer interesting and challenging projects that will be meaningful to the people they seek to hire,” reveals Groom.

“We help companies better communicate their corporate culture and corporate social responsibility to candidates, because it's something that candidates today are interested in. It’s not that salary isn’t important, but people are keenly interested in how a company is seeking to improve society, where they’ll fit in, what the working atmosphere is like, and how dedicated to diversity a company is.”

The Groom team is comprised of hiring experts from a myriad of cultural backgrounds and languages, and proudly reports that diversity is their strength. They believe that diversity is important not only for attracting top candidates, but for better employee retention rates and company success as a whole.

“We’ve decided to serve the specific industries that we believe have enormous growth potential. Our clients are benefitting from our narrowed focus and from our team of recruiters with backgrounds in technology and science; not to mention our dedication to promoting diversity.”

Miriam Groom
Groom and Associates
+1 514-288-3222
email us here


Source: EIN Presswire

Certified EMDR Therapist Micki Halloran to be Featured on CUTV News Radio

SANTA FE, NEW MEXICO, UNITED STATES, December 6, 2019 /EINPresswire.com/ — At some point in our lives, most of us will suffer from distressing or traumatic life events that may leave us emotionally scarred. We become broken, deeply distressed and without joy. This is because when bad things happen to us memories can linger and haunt us deeply. If left unhealed they will only compound over time. A part of us may even feel trapped, reliving the past. Trying to cope by self-medicating with drugs or alcohol only worsens our health and overall emotional well-being. A ground-breaking therapeutic approach EMDR (Eye movement Desensitization and Reprocessing), is proving that treating and healing trauma that once took years to be effective is now absolutely possible. EMDR is the most researched trauma therapy utilized today. Millions of people have been treated successfully over the past 25 years with EMDR. Over 100,000 therapists worldwide use EMDR therapy.

Micki Halloran MA LPC, LPCC is an exceptionally skilled Psychotherapist in private practice for over thirty-five years with a specialty in helping people heal from trauma and early and recent adverse life events. She is an EMDR Certified Therapist, Consultant and EMDR Institute Facilitator.

“Since I started utilizing EMDR with my clients in 2002, I have been astonished time and again witnessing individuals experience the benefits of healing that would otherwise have taken years to make a difference.”

Brain research shows our minds can heal from psychological traumas just as the body can heal from physical trauma. With EMDR therapy we see debilitating wounds not just heal but transform. Our amazing brain naturally wants to move toward healing but if the inner system is blocked or thrown out of balance by the impact of a disturbing event, the emotional wound can fester and cause more intense suffering. Once the block is removed, healing occurs. With EMDR emotional, physical and psychological blocks can be permanently removed.

Developed in 1987 by Francine Shapiro PhD, EMDR therapy uses the individual’s own rapid, rhythmic eye movements. EMDR is a phased, fixated method to healing trauma and other adverse life events by connecting the client to images and emotions related to the particular original experience encouraging the natural healing powers of the brain to move toward dramatic recovery.

Micki is also a certified Havening® practitioner. Havening®, originally known as Delta Wave Techniques is a deceptively simple technique which can remove the results of trauma or phobias in as little as one session. Therapists, nurses, coaches, midwives and doctors and more can receive Havening® training. Using distraction and applied or self- touch, usually on upper arms, face or hands, erases the encoding of the a particular trauma in the brain. The landscape of the brain is altered so that the thought of an event and its emotional impact are delinked permanently.

Micki’s objective is to see Havening® and EMDR become more prominently recognized and utilized by therapists worldwide. As a facilitator for these life-changing therapies she witnesses people’s lives change in positive ways again and again.

“There is a spiritual component in my work helping people find their own profound wisdom and tap into their own core strength and inner peace. No matter what hardships we have to endure there is promise and hope when we are open to healing,” says Micki. “Believe there is hope and always truly follow your heart and you can enter into a more joyful, productive and healthier life.”

CUTV News Radio will feature Micki Halloran in an interview with Jim Masters on Tuesday December 6th at 1 p.m. EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest please call (347) 996-3389

Written By: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Advanced Wound Management 2019 Global Market Outlook,Research,Trends and Forecast to 2025

WiseGuyReports.Com Publish a New Market Research Report On –“ Advanced Wound Management 2019 Global Market Outlook,Research,Trends and Forecast to 2025”.

PUNE, INDIA, December 6, 2019 /EINPresswire.com/ —

Advanced Wound Management Market 2019

Description: –

The global Advanced Wound Management market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Advanced Wound Management volume and value at global level, regional level and company level. From a global perspective, this report represents overall Advanced Wound Management market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Advanced Wound Management in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Advanced Wound Management manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/4677410-global-advanced-wound-management-market-professional-survey-report-2019

For more information or any query mail at sales@wiseguyreports.com

Listed Key Players

Smith & Nephew
3M Health Care
Molnlycke Health Care
ConvaTec
Medtronic
Systagenix Wound Management
Coloplast
Covidien
B. Braun Melsungen
BSN Medical
Medline Industries
Organogenesis

The report discussed market dynamics that is characterised by increasing innovative technological developments and other major factors driving the market growth. It highlights the industry volume and value at global level, regional level and company level. From a global perspective, this report represents the overall market size by analysing historical data and future prospect. The report studies market status and outlook of major global markets, from key players’ perspective, countries, product types and end industries. This report analyses the top players in global market, and splits the entire market by product type and applications/end industries. By geography, the regional analysis of the market is considered for key regions that includes Asia Pacific, North America, Europe, Latin America and Rest of the World.

Under the research study, important trends are identified and sales forecasts by product categories and major country markets are provided through 2025. These are industry sources and a considered assessment of the regulatory environment, healthcare policies, demographics and other factors that directly impact the market. The wider economic environment is also taken into account. The report examines strategies employed by market leading companies specializing in the specified market to meet the challenges of this highly competitive market, while also summarizing strategies employed by these companies to forestall competition. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

The research methodology involves primary research and secondary research. While primary research involves extensive interviews and analysis of the opinions provided by the primary respondents, the secondary research process involves extensive exploring through the secondary sources of information available in both public domain and paid sources. The primary research respondents include key opinion leaders and internal and external subject matter experts. The secondary data sources typically include trade association journals, company reports and publications, websites and publications by research agencies.

This report is designed to satisfy the information requirements of a wide variety of individuals involved in the marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in planning, marketing, research and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are functioning. Comprehensive analysis of the companies operating in global breakfast cereal market. Finally, the Growth Matrix analyses the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/4677410-global-advanced-wound-management-market-professional-survey-report-2019

Table of Contents – Major Key Points

1 Industry Overview of Advanced Wound Management
2 Manufacturing Cost Structure Analysis
3 Development and Manufacturing Plants Analysis of Advanced Wound Management
4 Key Figures of Major Manufacturers
5 Advanced Wound Management Regional Market Analysis
6 Advanced Wound Management Segment Market Analysis (by Type)
7 Advanced Wound Management Segment Market Analysis (by Application)
8 Advanced Wound Management Major Manufacturers Analysis

Continued….

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

NORAH TRENT
WiseGuy Research Consultants Pvt. Ltd.
08411985042
email us here


Source: EIN Presswire

Global Smart Sink Market Report 2019-2025 by Technology, Future Trends, Opportunities, Top Key Players and more…

A new market study, titled “2020 Global Smart Sink Market Outlook”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, December 6, 2019 /EINPresswire.com/ — Smart Sink Market

The smart sink is a high-tech product that combines high-tech special equipment and the latest electronic automatic control technology to convert it into kitchen appliances. The smart sink, which applies ultrasonic technology to the process of making the sink, combines ultrasonic cleaning technology with a traditional sink. This report focuses on Smart Sink volume and value at global level, regional level and company level. From a global perspective, this report represents overall Smart Sink market size by analyzing historical data and future prospect.

Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
ROBAM
Oulin
Franke
Blanco
Kohler
Elkay
Duravit
JOMOO
Moen
Huida
Primy

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4694188-2020-global-smart-sink-market-outlook

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Single Slot
Double Slot
Three Slots
Multi-slot

Segment by Application
On-line
Franchised Store
Shopping mall and Supermarket
Others

Table of Content:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst's Viewpoints/Conclusions
15 Appendix

View Detailed Report at https://www.wiseguyreports.com/reports/4694188-2020-global-smart-sink-market-outlook

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

NORAH TRENT
WISE GUY RESEARCH CONSULTANTS PVT LTD
+ +1 646-845-9349
email us here


Source: EIN Presswire